ADIPOQ and diabetes mellitus: We have previously reported the reversal of an inverse association between serum adiponectin and abdominal aortic calcification in the general population to a positive association in haemodialysis patients1, although accumulated evidence indicates that higher serum adiponectin might predict lower cardiovascular disease (CVD) risk in the general population and in diabetes mellitus (DM) patients2,3.